We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
-17.52%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$678M
(-26%)
Cap. Flow
-$151M
Cap. Flow
% of AUM
-7.77%
Top 10 Holdings %
Top 10 Hldgs %
19.26%
Holding
283
New
21
Increased
57
Reduced
116
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$32.9M |
| 2 |
Alkermes
ALKS
|
+$29.9M |
| 3 |
Lantheus
LNTH
|
+$21.8M |
| 4 |
ProFrac Holding
ACDC
|
+$17.2M |
| 5 |
Excelerate Energy
EE
|
+$15.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$47M |
| 2 |
United Parks & Resorts
PRKS
|
+$27.6M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$18.6M |
| 4 |
Diodes
DIOD
|
+$16.2M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.92% |
| 2 | Technology | 18.08% |
| 3 | Industrials | 17.14% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Financials | 11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Microsoft
MSFT
$2.93T
| $5.93M | 0.31% |
23,096
+278
| +1% | +$75.5K |
|
102
SkyWater Technology
SKYT
$1.54B
| $5.9M | 0.3% |
979,427
-19,556
| -2% | -$134K |
|
103
Ocular Therapeutix
OCUL
$1.96B
| $5.89M | 0.3% |
1,465,702
+173,797
| +13% | +$657K |
|
104
Ambarella
AMBA
$2.71B
| $5.88M | 0.3% |
89,747
-6,422
| -7% | -$517K |
|
105
Cytokinetics
CYTK
$10.9B
| $5.67M | 0.29% |
+144,310
| New | +$5.81M |
|
106
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
| $5.58M | 0.29% |
147,347
-10,100
| -6% | -$402K |
|
107
Trex
TREX
$4.69B
| $5.53M | 0.28% |
101,563
-69,850
| -41% | -$4.21M |
|
108
Noodles & Co
NDLS
$65.5M
| $5.39M | 0.28% |
143,286
| – | – |
|
|
SPNE
109
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $5.17M | 0.27% |
915,571
-6,373
| -0.7% | -$55.6K |
|
|
THRN
110
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $5.13M | 0.26% |
1,060,376
+42,007
| +4% | +$255K |
|
111
Babcock & Wilcox
BW
$1.47B
| $4.46M | 0.23% |
740,442
-9,023
| -1% | -$63.2K |
|
112
Arhaus
ARHS
$1.09B
| $4.19M | 0.22% |
930,321
-580
| -0.1% | -$3.8K |
|
113
Credo Technology Group
CRDO
$37.8B
| $3.96M | 0.2% |
+339,228
| New | +$3.94M |
|
114
Tilly's
TLYS
$121M
| $3.3M | 0.17% |
470,436
-205,293
| -30% | -$1.71M |
|
115
Alphabet (Google) Class A
GOOGL
$4.23T
| $2.83M | 0.15% |
25,980
-660
| -2% | -$77.7K |
|
|
HZNP
116
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.55M | 0.13% |
32,004
+1,482
| +5% | +$140K |
|
117
Amazon
AMZN
$2.66T
| $2.46M | 0.13% |
23,200
-1,100
| -5% | -$138K |
|
118
Generac Holdings
GNRC
$12.7B
| $2.37M | 0.12% |
11,236
-952
| -8% | -$234K |
|
119
PDF Solutions
PDFS
$2.14B
| $2.35M | 0.12% |
+109,026
| New | +$2.52M |
|
120
NVIDIA
NVDA
$4.91T
| $2.2M | 0.11% |
145,010
-20,000
| -12% | -$377K |
|
121
Zevia
ZVIA
$122M
| $2.14M | 0.11% |
762,211
+118,504
| +18% | +$367K |
|
122
CVRx
CVRX
$130M
| $2.09M | 0.11% |
347,496
-53,040
| -13% | -$305K |
|
123
Cheniere Energy
LNG
$55B
| $2.02M | 0.1% |
15,223
-435
| -3% | -$59.2K |
|
124
Supernus Pharmaceuticals
SUPN
$2.79B
| $2.02M | 0.1% |
+69,900
| New | +$2M |
|
125
WillScot Mobile Mini Holdings
WSC
$4.93B
| $2M | 0.1% |
61,821
+4,023
| +7% | +$142K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Emerald Advisers held 283 positions worth $1.94B, down 26% from $2.62B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Emerald Advisers withdrew a net $151M in Q2 2022, closing 33 positions and reducing 116 holdings. Its most notable exit was Diodes, an estimated $16.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
Against the trend, Emerald Advisers opened a new position in Tandem Diabetes Care worth $23.7M.
- Emerald Advisers's largest Q2 2022 buy was Tandem Diabetes Care: 400,931 shares worth $23.7M.
- Emerald Advisers added most to Petco in Q2 2022, an estimated $10.9M increase.
- Emerald Advisers's biggest Q2 2022 reduction was SailPoint Technologies Holdings, Inc. Common Stock, cutting an estimated $47M.
- Emerald Advisers fully exited Diodes in Q2 2022, selling an estimated $16.2M.
- Emerald Advisers's ten largest holdings make up 19% of its $1.94B portfolio in Q2 2022.
- Emerald Advisers opened 21 new positions and closed 33 in Q2 2022.
- Emerald Advisers's portfolio value fell 26% quarter-over-quarter to $1.94B.
Based on Emerald Advisers's 13F filing for Q2 2022, filed 29 Jul 2022.